Modeling of mesothelioma growth demonstrates weaknesses of current response criteria

March 10, 2006 |

Lung Cancer. 2006 Mar 9; [Epub ahead of print] [Link] Geoffrey R. Oxnarda, Samuel G. Armato IIIb, d and Hedy L. Kindlerc, d aDepartment of Medicine, Massachusetts General Hospital, 55…

Second cancers among 40,576 testicular cancer patients: focus on long-term survivors

March 8, 2006 |

Travis LB, Fossa SD, Schonfeld SJ, McMaster ML, Lynch CF, Storm H, Hall P, Holowaty E, Andersen A, Pukkala E, Andersson M, Kaijser M, Gospodarowicz M, Joensuu T, Cohen RJ,…

Cytogenetic toxicity of cycloplatam in human lymphocytes: detection by the micronucleus test and fluorescence in situ hybridization

March 8, 2006 |

Anticancer Drugs. 2006 Mar;17(3):289-95. [Link] Nersesyan A, Perrone E, Roggieri P, Bolognesi C. Cancer Research Center, Yerevan, Armenia Environmental Carcinogenesis Unit, National Cancer Research Institute, Genoa, Italy. Abstract Cycloplatam has…

Intrapleural topical application of cisplatin with the surgical carrier Vivostat increases the local drug concentration in an immune-competent rat model with malignant pleuromesothelioma

March 7, 2006 |

The Journal of Thoracic and Cardiovascular Surgery. 2006 Mar;131(3):697-703.e3. Received 2 June 2005;  revised 5 August 2005;  accepted 17 August 2005.  Available online 2 March 2006. [Link] D. Lardinois MDa,…

Wnt inhibitory factor-1, a Wnt antagonist, is silenced by promoter hypermethylation in malignant pleural mesothelioma

March 7, 2006 |

Biochemical and Biophysical Research Communications. Received 11 February 2006.  Available online 24 February 2006. [Link] Sonny Batraa, Yihui Shia, Kristopher M. Kuchenbeckera, Biao Hea, Noemi Reguarta, b, Iwao Mikamia, Liang…

Macroscopic, Histologic, Histochemical, Immunohistochemical, and Ultrastructural Features of Mesothelioma

March 7, 2006 |

Ultrastructural Pathology. 2006 Jan-Feb;30(1):3-17. [Link] Hammar SP. Diagnostic Specialties Laboratories, Bremerton, Washington, USA. Abstract Mesotheliomas are uncommon neoplasms that arise from the cells forming the serosal membranes of the body…

Biologic, Cytogenetic, and Molecular Factors in Mesothelial Proliferations

March 7, 2006 |

Ultrastructural Pathology. 2006 Jan-Feb;30(1):19-30. [Link] John Hicks A1 A1 Department of Pathology, Texas Children’s Hospital and Baylor College of Medicine, Houston, Texas, USA Abstract Although mesothelioma cases may have peaked in…

The Role of Analytical SEM in the Determination of Causation in Malignant Mesothelioma

March 7, 2006 |

Ultrastructural Pathology. 2006 Jan-Feb;30(1):31-5. [Link] Victor L. Roggli A1 A1 Department of Pathology, Duke University Medical Center, Durham, North Carolina, USA Abstract The causative relationship between asbestos exposure and mesothelioma is…

Phosphorylated Extracellular Signal-regulated Kinases are Significantly Increased in Malignant Mesothelioma

March 7, 2006 |

Journal of Histochemistry & Cytochemistry. 2006 Mar 3; [Epub ahead of print] [Link] Merivane de Melo 1, Margaret W. Gerbase 1, Joseph Curran 1 and Jean-Claude Pache 1* 1 Divisions…

Potential role of histone deacetylase inhibitors in mesothelioma: clinical experience with suberoylanilide hydroxamic Acid

March 6, 2006 |

Clinical Lung Cancer. 2006 Jan;7(4):257-61. [Link] Krug LM, Curley T, Schwartz L, Richardson S, Marks P, Chiao J, Kelly WK. Thoracic Oncology Service , Memorial Sloan-Kettering Cancer Center and Joan…

Categories